Rituximab for treatment of non-infectious and non-malignant orbital inflammatory disease

MLA

Caleb C. Ng, et al. “Rituximab for Treatment of Non-Infectious and Non-Malignant Orbital Inflammatory Disease.” Journal of Ophthalmic Inflammation and Infection, vol. 11, no. 1, Aug. 2021, pp. 1–12. EBSCOhost, https://doi.org/10.1186/s12348-021-00253-3.

APA

Caleb C. Ng, Aileen Sy, & Emmett T. Cunningham. (2021). Rituximab for treatment of non-infectious and non-malignant orbital inflammatory disease. Journal of Ophthalmic Inflammation and Infection, 11(1), 1–12. https://doi.org/10.1186/s12348-021-00253-3

Chicago

Caleb C. Ng, Aileen Sy, and Emmett T. Cunningham. 2021. “Rituximab for Treatment of Non-Infectious and Non-Malignant Orbital Inflammatory Disease.” Journal of Ophthalmic Inflammation and Infection 11 (1): 1–12. doi:10.1186/s12348-021-00253-3.